Review
[Pharmacological standards in schizophrenia treatment]
[Article in
Polish]
Affiliations
- PMID: 17444297
Item in Clipboard
Review
[Pharmacological standards in schizophrenia treatment]
[Article in
Polish]
Psychiatr Pol.
2006 Nov-Dec.
No abstract available
Similar articles
-
Do negative symptoms respond to pharmacological treatment?Br J Psychiatry Suppl. 1989 Nov;(7):115-8. Br J Psychiatry Suppl. 1989. PMID: 2575914 Review. No abstract available.
-
Simple schizophrenia in an adolescent.J Child Adolesc Psychopharmacol. 2009 Oct;19(5):589-90. doi: 10.1089/cap.2008.0121. J Child Adolesc Psychopharmacol. 2009. PMID: 19877985 No abstract available.
-
[Is depot formulation a long-term optimal treatment option?].Med Monatsschr Pharm. 2005 Nov;28(11):414-6. Med Monatsschr Pharm. 2005. PMID: 16309031 German. No abstract available.
-
[Compliance with treatment in schizophrenia and mood disorders].Duodecim. 2000;116(3):277-84. Duodecim. 2000. PMID: 11764451 Review. Finnish. No abstract available.
-
Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.Arch Gen Psychiatry. 2007 Jun;64(6):631-2. doi: 10.1001/archpsyc.64.6.631. Arch Gen Psychiatry. 2007. PMID: 17548745 No abstract available.
Cited by
-
Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia.Ann Gen Psychiatry. 2020 Jun 17;19:39. doi: 10.1186/s12991-020-00289-0. eCollection 2020. Ann Gen Psychiatry. 2020. PMID: 32565876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical